1. Home
  2. BWLP vs AORT Comparison

BWLP vs AORT Comparison

Compare BWLP & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BW LPG Limited

BWLP

BW LPG Limited

HOLD

Current Price

$16.57

Market Cap

2.0B

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$35.44

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWLP
AORT
Founded
1935
1984
Country
Singapore
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
BWLP
AORT
Price
$16.57
$35.44
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$48.76
AVG Volume (30 Days)
416.1K
315.1K
Earning Date
03-03-2026
05-04-2026
Dividend Yield
8.90%
N/A
EPS Growth
N/A
165.62
EPS
N/A
0.21
Revenue
N/A
$298,836,000.00
Revenue This Year
N/A
$14.20
Revenue Next Year
N/A
$11.17
P/E Ratio
$15.61
$168.57
Revenue Growth
N/A
18.01
52 Week Low
$7.86
$21.97
52 Week High
$18.84
$48.25

Technical Indicators

Market Signals
Indicator
BWLP
AORT
Relative Strength Index (RSI) 52.40 38.47
Support Level $13.43 $34.60
Resistance Level $18.84 $38.42
Average True Range (ATR) 0.47 1.12
MACD 0.10 0.03
Stochastic Oscillator 81.81 22.66

Price Performance

Historical Comparison
BWLP
AORT

About BWLP BW LPG Limited

BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: